Innogenix aims to develop, manufacture and commercialize niche, specialty and hard to manufacture Generic Drugs. Located on Long Island, Innogenix is an emerging generic and specialty pharmaceutical company that identifies, develops, manufactures and markets complex and difficult-to-manufacture generic prescription pharmaceutical products. Our goal is to create a portfolio of limited source branded and generic pharmaceutical products that will provide competitively price and affordable medicines of the highest quality and standards to physicians and patients in the United States. We have a diversified and robust product development pipeline that includes ANDAs, 505(b)(2)s as well as Paragraph IV filings.